|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:NADK2-CDH1 (FusionGDB2 ID:56770) |
Fusion Gene Summary for NADK2-CDH1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: NADK2-CDH1 | Fusion gene ID: 56770 | Hgene | Tgene | Gene symbol | NADK2 | CDH1 | Gene ID | 133686 | 51343 |
| Gene name | NAD kinase 2, mitochondrial | fizzy and cell division cycle 20 related 1 | |
| Synonyms | C5orf33|DECRD|MNADK|NADKD1 | CDC20C|CDH1|FZR|FZR2|HCDH|HCDH1 | |
| Cytomap | 5p13.2 | 19p13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | NAD kinase 2, mitochondrialNAD kinase domain-containing protein 1, mitochondrial | fizzy-related protein homologCDC20 homolog 1CDC20-like 1bCDC20-like protein 1cdh1/Hct1 homologfizzy/cell division cycle 20 related 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q4G0N4 | Q9H159 | |
| Ensembl transtripts involved in fusion gene | ENST00000397338, ENST00000282512, ENST00000381937, ENST00000511613, ENST00000506945, ENST00000514504, | ENST00000261769, ENST00000422392, ENST00000562836, | |
| Fusion gene scores | * DoF score | 7 X 8 X 4=224 | 19 X 20 X 5=1900 |
| # samples | 8 | 23 | |
| ** MAII score | log2(8/224*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(23/1900*10)=-3.04629365227394 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: NADK2 [Title/Abstract] AND CDH1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CDH1(68772314)-NADK2(36201263), # samples:2 NADK2(36207272)-CDH1(68835573), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | NADK2-CDH1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. NADK2-CDH1 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. NADK2-CDH1 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. CDH1-NADK2 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. CDH1-NADK2 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. CDH1-NADK2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | NADK2 | GO:0019674 | NAD metabolic process | 23212377 |
| Tgene | CDH1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 18662541|21596315 |
| Tgene | CDH1 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint | 18662541 |
| Tgene | CDH1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity | 11459826 |
| Fusion gene breakpoints across NADK2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across CDH1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-A2-A4RW-01A | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
Top |
Fusion Gene ORF analysis for NADK2-CDH1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000397338 | ENST00000261769 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| Frame-shift | ENST00000397338 | ENST00000422392 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| 5CDS-3UTR | ENST00000397338 | ENST00000562836 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| In-frame | ENST00000282512 | ENST00000261769 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| In-frame | ENST00000282512 | ENST00000422392 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| 5CDS-3UTR | ENST00000282512 | ENST00000562836 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| Frame-shift | ENST00000381937 | ENST00000261769 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| Frame-shift | ENST00000381937 | ENST00000422392 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| 5CDS-3UTR | ENST00000381937 | ENST00000562836 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| 5UTR-3CDS | ENST00000511613 | ENST00000261769 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| 5UTR-3CDS | ENST00000511613 | ENST00000422392 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| 5UTR-3UTR | ENST00000511613 | ENST00000562836 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| In-frame | ENST00000506945 | ENST00000261769 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| In-frame | ENST00000506945 | ENST00000422392 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| 5CDS-3UTR | ENST00000506945 | ENST00000562836 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| intron-3CDS | ENST00000514504 | ENST00000261769 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| intron-3CDS | ENST00000514504 | ENST00000422392 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| intron-3UTR | ENST00000514504 | ENST00000562836 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000282512 | NADK2 | chr5 | 36207272 | - | ENST00000261769 | CDH1 | chr16 | 68835573 | + | 5238 | 703 | 573 | 3188 | 871 |
| ENST00000282512 | NADK2 | chr5 | 36207272 | - | ENST00000422392 | CDH1 | chr16 | 68835573 | + | 3043 | 703 | 573 | 3005 | 810 |
| ENST00000506945 | NADK2 | chr5 | 36207272 | - | ENST00000261769 | CDH1 | chr16 | 68835573 | + | 5441 | 906 | 821 | 3391 | 856 |
| ENST00000506945 | NADK2 | chr5 | 36207272 | - | ENST00000422392 | CDH1 | chr16 | 68835573 | + | 3246 | 906 | 821 | 3208 | 795 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000282512 | ENST00000261769 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + | 0.000391771 | 0.9996082 |
| ENST00000282512 | ENST00000422392 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + | 0.001420322 | 0.99857974 |
| ENST00000506945 | ENST00000261769 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + | 0.000460439 | 0.9995396 |
| ENST00000506945 | ENST00000422392 | NADK2 | chr5 | 36207272 | - | CDH1 | chr16 | 68835573 | + | 0.001300045 | 0.9986999 |
Top |
Fusion Genomic Features for NADK2-CDH1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| NADK2 | chr5 | 36207271 | - | CDH1 | chr16 | 68835572 | + | 1.36E-07 | 0.9999999 |
| NADK2 | chr5 | 36207271 | - | CDH1 | chr16 | 68835572 | + | 1.36E-07 | 0.9999999 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for NADK2-CDH1 |
| Go to FGviewer for the breakpoints of chr5:36207272-chr16:68835573 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NADK2 | CDH1 |
| FUNCTION: Mitochondrial NAD(+) kinase that phosphorylates NAD(+) to yield NADP(+). Can use both ATP or inorganic polyphosphate as the phosphoryl donor. Also has weak NADH kinase activity in vitro; however NADH kinase activity is much weaker than the NAD(+) kinase activity and may not be relevant in vivo. {ECO:0000269|PubMed:23212377}. | FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 838_851 | 54.333333333333336 | 883.0 | Compositional bias | Note=Ser-rich | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 155_262 | 54.333333333333336 | 883.0 | Domain | Cadherin 1 | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 263_375 | 54.333333333333336 | 883.0 | Domain | Cadherin 2 | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 376_486 | 54.333333333333336 | 883.0 | Domain | Cadherin 3 | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 487_593 | 54.333333333333336 | 883.0 | Domain | Cadherin 4 | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 594_697 | 54.333333333333336 | 883.0 | Domain | Cadherin 5 | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 758_769 | 54.333333333333336 | 883.0 | Region | Note=Required for binding CTNND1 and PSEN1 | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 811_882 | 54.333333333333336 | 883.0 | Region | Note=Required for binding alpha%2C beta and gamma catenins | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 155_709 | 54.333333333333336 | 883.0 | Topological domain | Extracellular | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 731_882 | 54.333333333333336 | 883.0 | Topological domain | Cytoplasmic | |
| Tgene | CDH1 | chr5:36207272 | chr16:68835573 | ENST00000261769 | 1 | 16 | 710_730 | 54.333333333333336 | 883.0 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for NADK2-CDH1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000282512_ENST00000261769_TCGA-A2-A4RW-01A_NADK2_chr5_36207272_-_CDH1_chr16_68835573_length(transcript)=5238nt_BP=703nt GGTGCGGGGAGGTCGCCCCCGGGCGGCGAAGCAGCCATTATGCAGGCCTTGCATTGAAAGGCTCTAGTTACAGTGGACTTCTTGAACGAC ATCATATTCACACCAAAAATGTAGAACATATTATAGATAGTTTACGGAATGAGGGAATTGAGGTTCGTCTAGTAAAGAGGAGAGAATATG ATGAAGAGACTGTTCGATGGGCAGATGCTGTCATAGCTGCAGGAGGTGATGGCACAATGCTGCTGGCAGCGAGTAAAGTCTTGGACAGAC TTAAACCAGTTATAGGGGTAAACACTGATCCAGAACGGTCTGAGGGTCATTTATGCCTGCCCGTTCGATATACACATTCCTTTCCAGAAG CCTTACAGAAGTTCTATCGTGGTGAGTTCAGGTGGTTGTGGAGGCAGAGAATCAGGTTATACCTTGAAGGGACTGGCATAAACCCTGTAC CTGTGGACCTTCACGAGCAGCAGCTAAGCTTGAATCAGCACAATAGAGCCCTTAACATTGAAAGAGCTCATGATGAAAGGTCTGAGGCTT CAGGACCCCAACTTCTGCCAGTGAGAGCACTAAATGAAGTCTTCATTGGGGAGAGTCTGTCATCCAGGGCTTCCTACTATGAGATTTCAG TTGATGATGGTCCATGGGAAAAACAGAAGAGTTCAGGGCTCAATTTGTGTACTGGAACAGGATCAAAGGCCTGTGAATTTTGAAGATTGC ACCGGTCGACAAAGGACAGCCTATTTTTCCCTCGACACCCGATTCAAAGTGGGCACAGATGGTGTGATTACAGTCAAAAGGCCTCTACGG TTTCATAACCCACAGATCCATTTCTTGGTCTACGCCTGGGACTCCACCTACAGAAAGTTTTCCACCAAAGTCACGCTGAATACAGTGGGG CACCACCACCGCCCCCCGCCCCATCAGGCCTCCGTTTCTGGAATCCAAGCAGAATTGCTCACATTTCCCAACTCCTCTCCTGGCCTCAGA AGACAGAAGAGAGACTGGGTTATTCCTCCCATCAGCTGCCCAGAAAATGAAAAAGGCCCATTTCCTAAAAACCTGGTTCAGATCAAATCC AACAAAGACAAAGAAGGCAAGGTTTTCTACAGCATCACTGGCCAAGGAGCTGACACACCCCCTGTTGGTGTCTTTATTATTGAAAGAGAA ACAGGATGGCTGAAGGTGACAGAGCCTCTGGATAGAGAACGCATTGCCACATACACTCTCTTCTCTCACGCTGTGTCATCCAACGGGAAT GCAGTTGAGGATCCAATGGAGATTTTGATCACGGTAACCGATCAGAATGACAACAAGCCCGAATTCACCCAGGAGGTCTTTAAGGGGTCT GTCATGGAAGGTGCTCTTCCAGGAACCTCTGTGATGGAGGTCACAGCCACAGACGCGGACGATGATGTGAACACCTACAATGCCGCCATC GCTTACACCATCCTCAGCCAAGATCCTGAGCTCCCTGACAAAAATATGTTCACCATTAACAGGAACACAGGAGTCATCAGTGTGGTCACC ACTGGGCTGGACCGAGAGAGTTTCCCTACGTATACCCTGGTGGTTCAAGCTGCTGACCTTCAAGGTGAGGGGTTAAGCACAACAGCAACA GCTGTGATCACAGTCACTGACACCAACGATAATCCTCCGATCTTCAATCCCACCACGTACAAGGGTCAGGTGCCTGAGAACGAGGCTAAC GTCGTAATCACCACACTGAAAGTGACTGATGCTGATGCCCCCAATACCCCAGCGTGGGAGGCTGTATACACCATATTGAATGATGATGGT GGACAATTTGTCGTCACCACAAATCCAGTGAACAACGATGGCATTTTGAAAACAGCAAAGGGCTTGGATTTTGAGGCCAAGCAGCAGTAC ATTCTACACGTAGCAGTGACGAATGTGGTACCTTTTGAGGTCTCTCTCACCACCTCCACAGCCACCGTCACCGTGGATGTGCTGGATGTG AATGAAGCCCCCATCTTTGTGCCTCCTGAAAAGAGAGTGGAAGTGTCCGAGGACTTTGGCGTGGGCCAGGAAATCACATCCTACACTGCC CAGGAGCCAGACACATTTATGGAACAGAAAATAACATATCGGATTTGGAGAGACACTGCCAACTGGCTGGAGATTAATCCGGACACTGGT GCCATTTCCACTCGGGCTGAGCTGGACAGGGAGGATTTTGAGCACGTGAAGAACAGCACGTACACAGCCCTAATCATAGCTACAGACAAT GGTTCTCCAGTTGCTACTGGAACAGGGACACTTCTGCTGATCCTGTCTGATGTGAATGACAACGCCCCCATACCAGAACCTCGAACTATA TTCTTCTGTGAGAGGAATCCAAAGCCTCAGGTCATAAACATCATTGATGCAGACCTTCCTCCCAATACATCTCCCTTCACAGCAGAACTA ACACACGGGGCGAGTGCCAACTGGACCATTCAGTACAACGACCCAACCCAAGAATCTATCATTTTGAAGCCAAAGATGGCCTTAGAGGTG GGTGACTACAAAATCAATCTCAAGCTCATGGATAACCAGAATAAAGACCAAGTGACCACCTTAGAGGTCAGCGTGTGTGACTGTGAAGGG GCCGCTGGCGTCTGTAGGAAGGCACAGCCTGTCGAAGCAGGATTGCAAATTCCTGCCATTCTGGGGATTCTTGGAGGAATTCTTGCTTTG CTAATTCTGATTCTGCTGCTCTTGCTGTTTCTTCGGAGGAGAGCGGTGGTCAAAGAGCCCTTACTGCCCCCAGAGGATGACACCCGGGAC AACGTTTATTACTATGATGAAGAAGGAGGCGGAGAAGAGGACCAGGACTTTGACTTGAGCCAGCTGCACAGGGGCCTGGACGCTCGGCCT GAAGTGACTCGTAACGACGTTGCACCAACCCTCATGAGTGTCCCCCGGTATCTTCCCCGCCCTGCCAATCCCGATGAAATTGGAAATTTT ATTGATGAAAATCTGAAAGCGGCTGATACTGACCCCACAGCCCCGCCTTATGATTCTCTGCTCGTGTTTGACTATGAAGGAAGCGGTTCC GAAGCTGCTAGTCTGAGCTCCCTGAACTCCTCAGAGTCAGACAAAGACCAGGACTATGACTACTTGAACGAATGGGGCAATCGCTTCAAG AAGCTGGCTGACATGTACGGAGGCGGCGAGGACGACTAGGGGACTCGAGAGAGGCGGGCCCCAGACCCATGTGCTGGGAAATGCAGAAAT CACGTTGCTGGTGGTTTTTCAGCTCCCTTCCCTTGAGATGAGTTTCTGGGGAAAAAAAAGAGACTGGTTAGTGATGCAGTTAGTATAGCT TTATACTCTCTCCACTTTATAGCTCTAATAAGTTTGTGTTAGAAAAGTTTCGACTTATTTCTTAAAGCTTTTTTTTTTTTCCCATCACTC TTTACATGGTGGTGATGTCCAAAAGATACCCAAATTTTAATATTCCAGAAGAACAACTTTAGCATCAGAAGGTTCACCCAGCACCTTGCA GATTTTCTTAAGGAATTTTGTCTCACTTTTAAAAAGAAGGGGAGAAGTCAGCTACTCTAGTTCTGTTGTTTTGTGTATATAATTTTTTAA AAAAAATTTGTGTGCTTCTGCTCATTACTACACTGGTGTGTCCCTCTGCCTTTTTTTTTTTTTTAAGACAGGGTCTCATTCTATCGGCCA GGCTGGAGTGCAGTGGTGCAATCACAGCTCACTGCAGCCTTGTCCTCCCAGGCTCAAGCTATCCTTGCACCTCAGCCTCCCAAGTAGCTG GGACCACAGGCATGCACCACTACGCATGACTAATTTTTTAAATATTTGAGACGGGGTCTCCCTGTGTTACCCAGGCTGGTCTCAAACTCC TGGGCTCAAGTGATCCTCCCATCTTGGCCTCCCAGAGTATTGGGATTACAGACATGAGCCACTGCACCTGCCCAGCTCCCCAACTCCCTG CCATTTTTTAAGAGACAGTTTCGCTCCATCGCCCAGGCCTGGGATGCAGTGATGTGATCATAGCTCACTGTAACCTCAAACTCTGGGGCT CAAGCAGTTCTCCCACCAGCCTCCTTTTTATTTTTTTGTACAGATGGGGTCTTGCTATGTTGCCCAAGCTGGTCTTAAACTCCTGGCCTC AAGCAATCCTTCTGCCTTGGCCCCCCAAAGTGCTGGGATTGTGGGCATGAGCTGCTGTGCCCAGCCTCCATGTTTTAATATCAACTCTCA CTCCTGAATTCAGTTGCTTTGCCCAAGATAGGAGTTCTCTGATGCAGAAATTATTGGGCTCTTTTAGGGTAAGAAGTTTGTGTCTTTGTC TGGCCACATCTTGACTAGGTATTGTCTACTCTGAAGACCTTTAATGGCTTCCCTCTTTCATCTCCTGAGTATGTAACTTGCAATGGGCAG CTATCCAGTGACTTGTTCTGAGTAAGTGTGTTCATTAATGTTTATTTAGCTCTGAAGCAAGAGTGATATACTCCAGGACTTAGAATAGTG CCTAAAGTGCTGCAGCCAAAGACAGAGCGGAACTATGAAAAGTGGGCTTGGAGATGGCAGGAGAGCTTGTCATTGAGCCTGGCAATTTAG CAAACTGATGCTGAGGATGATTGAGGTGGGTCTACCTCATCTCTGAAAATTCTGGAAGGAATGGAGGAGTCTCAACATGTGTTTCTGACA CAAGATCCGTGGTTTGTACTCAAAGCCCAGAATCCCCAAGTGCCTGCTTTTGATGATGTCTACAGAAAATGCTGGCTGAGCTGAACACAT TTGCCCAATTCCAGGTGTGCACAGAAAACCGAGAATATTCAAAATTCCAAATTTTTTTCTTAGGAGCAAGAAGAAAATGTGGCCCTAAAG GGGGTTAGTTGAGGGGTAGGGGGTAGTGAGGATCTTGATTTGGATCTCTTTTTATTTAAATGTGAATTTCAACTTTTGACAATCAAAGAA AAGACTTTTGTTGAAATAGCTTTACTGTTTCTCAAGTGTTTTGGAGAAAAAAATCAACCCTGCAATCACTTTTTGGAATTGTCTTGATTT TTCGGCAGTTCAAGCTATATCGAATATAGTTCTGTGTAGAGAATGTCACTGTAGTTTTGAGTGTATACATGTGTGGGTGCTGATAATTGT GTATTTTCTTTGGGGGTGGAAAAGGAAAACAATTCAAGCTGAGAAAAGTATTCTCAAAGATGCATTTTTATAAATTTTATTAAACAATTT >In-frame_ENST00000282512_ENST00000261769_TCGA-A2-A4RW-01A_NADK2_chr5_36207272_-_CDH1_chr16_68835573_length(amino acids)=871AA_start in transcript=573_stop in transcript=3188 MKSSLGRVCHPGLPTMRFQLMMVHGKNRRVQGSICVLEQDQRPVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLRFHNPQIHFLVY AWDSTYRKFSTKVTLNTVGHHHRPPPHQASVSGIQAELLTFPNSSPGLRRQKRDWVIPPISCPENEKGPFPKNLVQIKSNKDKEGKVFYS ITGQGADTPPVGVFIIERETGWLKVTEPLDRERIATYTLFSHAVSSNGNAVEDPMEILITVTDQNDNKPEFTQEVFKGSVMEGALPGTSV MEVTATDADDDVNTYNAAIAYTILSQDPELPDKNMFTINRNTGVISVVTTGLDRESFPTYTLVVQAADLQGEGLSTTATAVITVTDTNDN PPIFNPTTYKGQVPENEANVVITTLKVTDADAPNTPAWEAVYTILNDDGGQFVVTTNPVNNDGILKTAKGLDFEAKQQYILHVAVTNVVP FEVSLTTSTATVTVDVLDVNEAPIFVPPEKRVEVSEDFGVGQEITSYTAQEPDTFMEQKITYRIWRDTANWLEINPDTGAISTRAELDRE DFEHVKNSTYTALIIATDNGSPVATGTGTLLLILSDVNDNAPIPEPRTIFFCERNPKPQVINIIDADLPPNTSPFTAELTHGASANWTIQ YNDPTQESIILKPKMALEVGDYKINLKLMDNQNKDQVTTLEVSVCDCEGAAGVCRKAQPVEAGLQIPAILGILGGILALLILILLLLLFL RRRAVVKEPLLPPEDDTRDNVYYYDEEGGGEEDQDFDLSQLHRGLDARPEVTRNDVAPTLMSVPRYLPRPANPDEIGNFIDENLKAADTD -------------------------------------------------------------- >In-frame_ENST00000282512_ENST00000422392_TCGA-A2-A4RW-01A_NADK2_chr5_36207272_-_CDH1_chr16_68835573_length(transcript)=3043nt_BP=703nt GGTGCGGGGAGGTCGCCCCCGGGCGGCGAAGCAGCCATTATGCAGGCCTTGCATTGAAAGGCTCTAGTTACAGTGGACTTCTTGAACGAC ATCATATTCACACCAAAAATGTAGAACATATTATAGATAGTTTACGGAATGAGGGAATTGAGGTTCGTCTAGTAAAGAGGAGAGAATATG ATGAAGAGACTGTTCGATGGGCAGATGCTGTCATAGCTGCAGGAGGTGATGGCACAATGCTGCTGGCAGCGAGTAAAGTCTTGGACAGAC TTAAACCAGTTATAGGGGTAAACACTGATCCAGAACGGTCTGAGGGTCATTTATGCCTGCCCGTTCGATATACACATTCCTTTCCAGAAG CCTTACAGAAGTTCTATCGTGGTGAGTTCAGGTGGTTGTGGAGGCAGAGAATCAGGTTATACCTTGAAGGGACTGGCATAAACCCTGTAC CTGTGGACCTTCACGAGCAGCAGCTAAGCTTGAATCAGCACAATAGAGCCCTTAACATTGAAAGAGCTCATGATGAAAGGTCTGAGGCTT CAGGACCCCAACTTCTGCCAGTGAGAGCACTAAATGAAGTCTTCATTGGGGAGAGTCTGTCATCCAGGGCTTCCTACTATGAGATTTCAG TTGATGATGGTCCATGGGAAAAACAGAAGAGTTCAGGGCTCAATTTGTGTACTGGAACAGGATCAAAGGCCTGTGAATTTTGAAGATTGC ACCGGTCGACAAAGGACAGCCTATTTTTCCCTCGACACCCGATTCAAAGTGGGCACAGATGGTGTGATTACAGTCAAAAGGCCTCTACGG TTTCATAACCCACAGATCCATTTCTTGGTCTACGCCTGGGACTCCACCTACAGAAAGTTTTCCACCAAAGTCACGCTGAATACAGTGGGG CACCACCACCGCCCCCCGCCCCATCAGGCCTCCGTTTCTGGAATCCAAGCAGAATTGCTCACATTTCCCAACTCCTCTCCTGGCCTCAGA AGACAGAAGAGAGACTGGGTTATTCCTCCCATCAGCTGCCCAGAAAATGAAAAAGGCCCATTTCCTAAAAACCTGGTTCAGATCAAATCC AACAAAGACAAAGAAGGCAAGGTTTTCTACAGCATCACTGGCCAAGGAGCTGACACACCCCCTGTTGGTGTCTTTATTATTGAAAGAGAA ACAGGATGGCTGAAGGTGACAGAGCCTCTGGATAGAGAACGCATTGCCACATACACTCTCTTCTCTCACGCTGTGTCATCCAACGGGAAT GCAGTTGAGGATCCAATGGAGATTTTGATCACGGTAACCGATCAGAATGACAACAAGCCCGAATTCACCCAGGAGGTCTTTAAGGGGTCT GTCATGGAAGGTGCTCTTCCAGGAACCTCTGTGATGGAGGTCACAGCCACAGACGCGGACGATGATGTGAACACCTACAATGCCGCCATC GCTTACACCATCCTCAGCCAAGATCCTGAGCTCCCTGACAAAAATATGTTCACCATTAACAGGAACACAGGAGTCATCAGTGTGGTCACC ACTGGGCTGGACCGAGAGAGTTTCCCTACGTATACCCTGGTGGTTCAAGCTGCTGACCTTCAAGGTGAGGGGTTAAGCACAACAGCAACA GCTGTGATCACAGTCACTGACACCAACGATAATCCTCCGATCTTCAATCCCACCACGGGCTTGGATTTTGAGGCCAAGCAGCAGTACATT CTACACGTAGCAGTGACGAATGTGGTACCTTTTGAGGTCTCTCTCACCACCTCCACAGCCACCGTCACCGTGGATGTGCTGGATGTGAAT GAAGCCCCCATCTTTGTGCCTCCTGAAAAGAGAGTGGAAGTGTCCGAGGACTTTGGCGTGGGCCAGGAAATCACATCCTACACTGCCCAG GAGCCAGACACATTTATGGAACAGAAAATAACATATCGGATTTGGAGAGACACTGCCAACTGGCTGGAGATTAATCCGGACACTGGTGCC ATTTCCACTCGGGCTGAGCTGGACAGGGAGGATTTTGAGCACGTGAAGAACAGCACGTACACAGCCCTAATCATAGCTACAGACAATGGT TCTCCAGTTGCTACTGGAACAGGGACACTTCTGCTGATCCTGTCTGATGTGAATGACAACGCCCCCATACCAGAACCTCGAACTATATTC TTCTGTGAGAGGAATCCAAAGCCTCAGGTCATAAACATCATTGATGCAGACCTTCCTCCCAATACATCTCCCTTCACAGCAGAACTAACA CACGGGGCGAGTGCCAACTGGACCATTCAGTACAACGACCCAACCCAAGAATCTATCATTTTGAAGCCAAAGATGGCCTTAGAGGTGGGT GACTACAAAATCAATCTCAAGCTCATGGATAACCAGAATAAAGACCAAGTGACCACCTTAGAGGTCAGCGTGTGTGACTGTGAAGGGGCC GCTGGCGTCTGTAGGAAGGCACAGCCTGTCGAAGCAGGATTGCAAATTCCTGCCATTCTGGGGATTCTTGGAGGAATTCTTGCTTTGCTA ATTCTGATTCTGCTGCTCTTGCTGTTTCTTCGGAGGAGAGCGGTGGTCAAAGAGCCCTTACTGCCCCCAGAGGATGACACCCGGGACAAC GTTTATTACTATGATGAAGAAGGAGGCGGAGAAGAGGACCAGGACTTTGACTTGAGCCAGCTGCACAGGGGCCTGGACGCTCGGCCTGAA GTGACTCGTAACGACGTTGCACCAACCCTCATGAGTGTCCCCCGGTATCTTCCCCGCCCTGCCAATCCCGATGAAATTGGAAATTTTATT GATGAAAATCTGAAAGCGGCTGATACTGACCCCACAGCCCCGCCTTATGATTCTCTGCTCGTGTTTGACTATGAAGGAAGCGGTTCCGAA GCTGCTAGTCTGAGCTCCCTGAACTCCTCAGAGTCAGACAAAGACCAGGACTATGACTACTTGAACGAATGGGGCAATCGCTTCAAGAAG >In-frame_ENST00000282512_ENST00000422392_TCGA-A2-A4RW-01A_NADK2_chr5_36207272_-_CDH1_chr16_68835573_length(amino acids)=810AA_start in transcript=573_stop in transcript=3005 MKSSLGRVCHPGLPTMRFQLMMVHGKNRRVQGSICVLEQDQRPVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLRFHNPQIHFLVY AWDSTYRKFSTKVTLNTVGHHHRPPPHQASVSGIQAELLTFPNSSPGLRRQKRDWVIPPISCPENEKGPFPKNLVQIKSNKDKEGKVFYS ITGQGADTPPVGVFIIERETGWLKVTEPLDRERIATYTLFSHAVSSNGNAVEDPMEILITVTDQNDNKPEFTQEVFKGSVMEGALPGTSV MEVTATDADDDVNTYNAAIAYTILSQDPELPDKNMFTINRNTGVISVVTTGLDRESFPTYTLVVQAADLQGEGLSTTATAVITVTDTNDN PPIFNPTTGLDFEAKQQYILHVAVTNVVPFEVSLTTSTATVTVDVLDVNEAPIFVPPEKRVEVSEDFGVGQEITSYTAQEPDTFMEQKIT YRIWRDTANWLEINPDTGAISTRAELDREDFEHVKNSTYTALIIATDNGSPVATGTGTLLLILSDVNDNAPIPEPRTIFFCERNPKPQVI NIIDADLPPNTSPFTAELTHGASANWTIQYNDPTQESIILKPKMALEVGDYKINLKLMDNQNKDQVTTLEVSVCDCEGAAGVCRKAQPVE AGLQIPAILGILGGILALLILILLLLLFLRRRAVVKEPLLPPEDDTRDNVYYYDEEGGGEEDQDFDLSQLHRGLDARPEVTRNDVAPTLM SVPRYLPRPANPDEIGNFIDENLKAADTDPTAPPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYGGGEDD -------------------------------------------------------------- >In-frame_ENST00000506945_ENST00000261769_TCGA-A2-A4RW-01A_NADK2_chr5_36207272_-_CDH1_chr16_68835573_length(transcript)=5441nt_BP=906nt ATCGCCTAACAGAATTCTACCTCTTTCTCAGGCCGCAGCCAATGGCGCGGCCCCTCGGATCCGGAGCCGCCGCGGGCTCTGATTGGCCGA TAGAGTTAGCCTGGGGGCGGGAGAAGAGCGACCTCGGGGAAGCGTGTGGTGCGGGGAGGTCGCCCCCGGGCGGCGAAGCAGCCATTATGC AGGCCTTGCATTGAAAGGCTCTAGTTACAGTGGACTTCTTGAACGACATCATATTCACACCAAAAATGTAGAACATATTATAGATAGTTT ACGGAATGAGGGAATTGAGGTTCGTCTAGTAAAGAGGAGAGAATATGATGAAGAGACTGTTCGATGGGCAGATGCTGTCATAGCTGCAGG AGGTGATGGCACAATGCTGCTGGCAGCGAGTAAAGTCTTGGACAGACTTAAACCAGTTATAGGGGTAAACACTGATCCAGAACGGTCTGA GGGTCATTTATGCCTGCCCGTTCGATATACACATTCCTTTCCAGAAGCCTTACAGAAGTTCTATCGTGGTGAGTTCAGGTGGTTGTGGAG GCAGAGAATCAGGTTATACCTTGAAGGGACTGGCATAAACCCTGTACCTGTGGACCTTCACGAGCAGCAGCTAAGCTTGAATCAGCACAA TAGAGCCCTTAACATTGAAAGAGCTCATGATGAAAGGTCTGAGGCTTCAGGACCCCAACTTCTGCCAGTGAGAGCACTAAATGAAGTCTT CATTGGGGAGAGTCTGTCATCCAGAATGTCTTATTCTTGGGCTGTAGCAGTGGACAATTTAAGAAGAAGTATACCCACTCTAAAGGGACT GGCTTCCTACTATGAGATTTCAGTTGATGATGGTCCATGGGAAAAACAGAAGAGTTCAGGGCTCAATTTGTGTACTGGAACAGGATCAAA GGCCTGTGAATTTTGAAGATTGCACCGGTCGACAAAGGACAGCCTATTTTTCCCTCGACACCCGATTCAAAGTGGGCACAGATGGTGTGA TTACAGTCAAAAGGCCTCTACGGTTTCATAACCCACAGATCCATTTCTTGGTCTACGCCTGGGACTCCACCTACAGAAAGTTTTCCACCA AAGTCACGCTGAATACAGTGGGGCACCACCACCGCCCCCCGCCCCATCAGGCCTCCGTTTCTGGAATCCAAGCAGAATTGCTCACATTTC CCAACTCCTCTCCTGGCCTCAGAAGACAGAAGAGAGACTGGGTTATTCCTCCCATCAGCTGCCCAGAAAATGAAAAAGGCCCATTTCCTA AAAACCTGGTTCAGATCAAATCCAACAAAGACAAAGAAGGCAAGGTTTTCTACAGCATCACTGGCCAAGGAGCTGACACACCCCCTGTTG GTGTCTTTATTATTGAAAGAGAAACAGGATGGCTGAAGGTGACAGAGCCTCTGGATAGAGAACGCATTGCCACATACACTCTCTTCTCTC ACGCTGTGTCATCCAACGGGAATGCAGTTGAGGATCCAATGGAGATTTTGATCACGGTAACCGATCAGAATGACAACAAGCCCGAATTCA CCCAGGAGGTCTTTAAGGGGTCTGTCATGGAAGGTGCTCTTCCAGGAACCTCTGTGATGGAGGTCACAGCCACAGACGCGGACGATGATG TGAACACCTACAATGCCGCCATCGCTTACACCATCCTCAGCCAAGATCCTGAGCTCCCTGACAAAAATATGTTCACCATTAACAGGAACA CAGGAGTCATCAGTGTGGTCACCACTGGGCTGGACCGAGAGAGTTTCCCTACGTATACCCTGGTGGTTCAAGCTGCTGACCTTCAAGGTG AGGGGTTAAGCACAACAGCAACAGCTGTGATCACAGTCACTGACACCAACGATAATCCTCCGATCTTCAATCCCACCACGTACAAGGGTC AGGTGCCTGAGAACGAGGCTAACGTCGTAATCACCACACTGAAAGTGACTGATGCTGATGCCCCCAATACCCCAGCGTGGGAGGCTGTAT ACACCATATTGAATGATGATGGTGGACAATTTGTCGTCACCACAAATCCAGTGAACAACGATGGCATTTTGAAAACAGCAAAGGGCTTGG ATTTTGAGGCCAAGCAGCAGTACATTCTACACGTAGCAGTGACGAATGTGGTACCTTTTGAGGTCTCTCTCACCACCTCCACAGCCACCG TCACCGTGGATGTGCTGGATGTGAATGAAGCCCCCATCTTTGTGCCTCCTGAAAAGAGAGTGGAAGTGTCCGAGGACTTTGGCGTGGGCC AGGAAATCACATCCTACACTGCCCAGGAGCCAGACACATTTATGGAACAGAAAATAACATATCGGATTTGGAGAGACACTGCCAACTGGC TGGAGATTAATCCGGACACTGGTGCCATTTCCACTCGGGCTGAGCTGGACAGGGAGGATTTTGAGCACGTGAAGAACAGCACGTACACAG CCCTAATCATAGCTACAGACAATGGTTCTCCAGTTGCTACTGGAACAGGGACACTTCTGCTGATCCTGTCTGATGTGAATGACAACGCCC CCATACCAGAACCTCGAACTATATTCTTCTGTGAGAGGAATCCAAAGCCTCAGGTCATAAACATCATTGATGCAGACCTTCCTCCCAATA CATCTCCCTTCACAGCAGAACTAACACACGGGGCGAGTGCCAACTGGACCATTCAGTACAACGACCCAACCCAAGAATCTATCATTTTGA AGCCAAAGATGGCCTTAGAGGTGGGTGACTACAAAATCAATCTCAAGCTCATGGATAACCAGAATAAAGACCAAGTGACCACCTTAGAGG TCAGCGTGTGTGACTGTGAAGGGGCCGCTGGCGTCTGTAGGAAGGCACAGCCTGTCGAAGCAGGATTGCAAATTCCTGCCATTCTGGGGA TTCTTGGAGGAATTCTTGCTTTGCTAATTCTGATTCTGCTGCTCTTGCTGTTTCTTCGGAGGAGAGCGGTGGTCAAAGAGCCCTTACTGC CCCCAGAGGATGACACCCGGGACAACGTTTATTACTATGATGAAGAAGGAGGCGGAGAAGAGGACCAGGACTTTGACTTGAGCCAGCTGC ACAGGGGCCTGGACGCTCGGCCTGAAGTGACTCGTAACGACGTTGCACCAACCCTCATGAGTGTCCCCCGGTATCTTCCCCGCCCTGCCA ATCCCGATGAAATTGGAAATTTTATTGATGAAAATCTGAAAGCGGCTGATACTGACCCCACAGCCCCGCCTTATGATTCTCTGCTCGTGT TTGACTATGAAGGAAGCGGTTCCGAAGCTGCTAGTCTGAGCTCCCTGAACTCCTCAGAGTCAGACAAAGACCAGGACTATGACTACTTGA ACGAATGGGGCAATCGCTTCAAGAAGCTGGCTGACATGTACGGAGGCGGCGAGGACGACTAGGGGACTCGAGAGAGGCGGGCCCCAGACC CATGTGCTGGGAAATGCAGAAATCACGTTGCTGGTGGTTTTTCAGCTCCCTTCCCTTGAGATGAGTTTCTGGGGAAAAAAAAGAGACTGG TTAGTGATGCAGTTAGTATAGCTTTATACTCTCTCCACTTTATAGCTCTAATAAGTTTGTGTTAGAAAAGTTTCGACTTATTTCTTAAAG CTTTTTTTTTTTTCCCATCACTCTTTACATGGTGGTGATGTCCAAAAGATACCCAAATTTTAATATTCCAGAAGAACAACTTTAGCATCA GAAGGTTCACCCAGCACCTTGCAGATTTTCTTAAGGAATTTTGTCTCACTTTTAAAAAGAAGGGGAGAAGTCAGCTACTCTAGTTCTGTT GTTTTGTGTATATAATTTTTTAAAAAAAATTTGTGTGCTTCTGCTCATTACTACACTGGTGTGTCCCTCTGCCTTTTTTTTTTTTTTAAG ACAGGGTCTCATTCTATCGGCCAGGCTGGAGTGCAGTGGTGCAATCACAGCTCACTGCAGCCTTGTCCTCCCAGGCTCAAGCTATCCTTG CACCTCAGCCTCCCAAGTAGCTGGGACCACAGGCATGCACCACTACGCATGACTAATTTTTTAAATATTTGAGACGGGGTCTCCCTGTGT TACCCAGGCTGGTCTCAAACTCCTGGGCTCAAGTGATCCTCCCATCTTGGCCTCCCAGAGTATTGGGATTACAGACATGAGCCACTGCAC CTGCCCAGCTCCCCAACTCCCTGCCATTTTTTAAGAGACAGTTTCGCTCCATCGCCCAGGCCTGGGATGCAGTGATGTGATCATAGCTCA CTGTAACCTCAAACTCTGGGGCTCAAGCAGTTCTCCCACCAGCCTCCTTTTTATTTTTTTGTACAGATGGGGTCTTGCTATGTTGCCCAA GCTGGTCTTAAACTCCTGGCCTCAAGCAATCCTTCTGCCTTGGCCCCCCAAAGTGCTGGGATTGTGGGCATGAGCTGCTGTGCCCAGCCT CCATGTTTTAATATCAACTCTCACTCCTGAATTCAGTTGCTTTGCCCAAGATAGGAGTTCTCTGATGCAGAAATTATTGGGCTCTTTTAG GGTAAGAAGTTTGTGTCTTTGTCTGGCCACATCTTGACTAGGTATTGTCTACTCTGAAGACCTTTAATGGCTTCCCTCTTTCATCTCCTG AGTATGTAACTTGCAATGGGCAGCTATCCAGTGACTTGTTCTGAGTAAGTGTGTTCATTAATGTTTATTTAGCTCTGAAGCAAGAGTGAT ATACTCCAGGACTTAGAATAGTGCCTAAAGTGCTGCAGCCAAAGACAGAGCGGAACTATGAAAAGTGGGCTTGGAGATGGCAGGAGAGCT TGTCATTGAGCCTGGCAATTTAGCAAACTGATGCTGAGGATGATTGAGGTGGGTCTACCTCATCTCTGAAAATTCTGGAAGGAATGGAGG AGTCTCAACATGTGTTTCTGACACAAGATCCGTGGTTTGTACTCAAAGCCCAGAATCCCCAAGTGCCTGCTTTTGATGATGTCTACAGAA AATGCTGGCTGAGCTGAACACATTTGCCCAATTCCAGGTGTGCACAGAAAACCGAGAATATTCAAAATTCCAAATTTTTTTCTTAGGAGC AAGAAGAAAATGTGGCCCTAAAGGGGGTTAGTTGAGGGGTAGGGGGTAGTGAGGATCTTGATTTGGATCTCTTTTTATTTAAATGTGAAT TTCAACTTTTGACAATCAAAGAAAAGACTTTTGTTGAAATAGCTTTACTGTTTCTCAAGTGTTTTGGAGAAAAAAATCAACCCTGCAATC ACTTTTTGGAATTGTCTTGATTTTTCGGCAGTTCAAGCTATATCGAATATAGTTCTGTGTAGAGAATGTCACTGTAGTTTTGAGTGTATA CATGTGTGGGTGCTGATAATTGTGTATTTTCTTTGGGGGTGGAAAAGGAAAACAATTCAAGCTGAGAAAAGTATTCTCAAAGATGCATTT >In-frame_ENST00000506945_ENST00000261769_TCGA-A2-A4RW-01A_NADK2_chr5_36207272_-_CDH1_chr16_68835573_length(amino acids)=856AA_start in transcript=821_stop in transcript=3391 MRFQLMMVHGKNRRVQGSICVLEQDQRPVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLRFHNPQIHFLVYAWDSTYRKFSTKVTL NTVGHHHRPPPHQASVSGIQAELLTFPNSSPGLRRQKRDWVIPPISCPENEKGPFPKNLVQIKSNKDKEGKVFYSITGQGADTPPVGVFI IERETGWLKVTEPLDRERIATYTLFSHAVSSNGNAVEDPMEILITVTDQNDNKPEFTQEVFKGSVMEGALPGTSVMEVTATDADDDVNTY NAAIAYTILSQDPELPDKNMFTINRNTGVISVVTTGLDRESFPTYTLVVQAADLQGEGLSTTATAVITVTDTNDNPPIFNPTTYKGQVPE NEANVVITTLKVTDADAPNTPAWEAVYTILNDDGGQFVVTTNPVNNDGILKTAKGLDFEAKQQYILHVAVTNVVPFEVSLTTSTATVTVD VLDVNEAPIFVPPEKRVEVSEDFGVGQEITSYTAQEPDTFMEQKITYRIWRDTANWLEINPDTGAISTRAELDREDFEHVKNSTYTALII ATDNGSPVATGTGTLLLILSDVNDNAPIPEPRTIFFCERNPKPQVINIIDADLPPNTSPFTAELTHGASANWTIQYNDPTQESIILKPKM ALEVGDYKINLKLMDNQNKDQVTTLEVSVCDCEGAAGVCRKAQPVEAGLQIPAILGILGGILALLILILLLLLFLRRRAVVKEPLLPPED DTRDNVYYYDEEGGGEEDQDFDLSQLHRGLDARPEVTRNDVAPTLMSVPRYLPRPANPDEIGNFIDENLKAADTDPTAPPYDSLLVFDYE -------------------------------------------------------------- >In-frame_ENST00000506945_ENST00000422392_TCGA-A2-A4RW-01A_NADK2_chr5_36207272_-_CDH1_chr16_68835573_length(transcript)=3246nt_BP=906nt ATCGCCTAACAGAATTCTACCTCTTTCTCAGGCCGCAGCCAATGGCGCGGCCCCTCGGATCCGGAGCCGCCGCGGGCTCTGATTGGCCGA TAGAGTTAGCCTGGGGGCGGGAGAAGAGCGACCTCGGGGAAGCGTGTGGTGCGGGGAGGTCGCCCCCGGGCGGCGAAGCAGCCATTATGC AGGCCTTGCATTGAAAGGCTCTAGTTACAGTGGACTTCTTGAACGACATCATATTCACACCAAAAATGTAGAACATATTATAGATAGTTT ACGGAATGAGGGAATTGAGGTTCGTCTAGTAAAGAGGAGAGAATATGATGAAGAGACTGTTCGATGGGCAGATGCTGTCATAGCTGCAGG AGGTGATGGCACAATGCTGCTGGCAGCGAGTAAAGTCTTGGACAGACTTAAACCAGTTATAGGGGTAAACACTGATCCAGAACGGTCTGA GGGTCATTTATGCCTGCCCGTTCGATATACACATTCCTTTCCAGAAGCCTTACAGAAGTTCTATCGTGGTGAGTTCAGGTGGTTGTGGAG GCAGAGAATCAGGTTATACCTTGAAGGGACTGGCATAAACCCTGTACCTGTGGACCTTCACGAGCAGCAGCTAAGCTTGAATCAGCACAA TAGAGCCCTTAACATTGAAAGAGCTCATGATGAAAGGTCTGAGGCTTCAGGACCCCAACTTCTGCCAGTGAGAGCACTAAATGAAGTCTT CATTGGGGAGAGTCTGTCATCCAGAATGTCTTATTCTTGGGCTGTAGCAGTGGACAATTTAAGAAGAAGTATACCCACTCTAAAGGGACT GGCTTCCTACTATGAGATTTCAGTTGATGATGGTCCATGGGAAAAACAGAAGAGTTCAGGGCTCAATTTGTGTACTGGAACAGGATCAAA GGCCTGTGAATTTTGAAGATTGCACCGGTCGACAAAGGACAGCCTATTTTTCCCTCGACACCCGATTCAAAGTGGGCACAGATGGTGTGA TTACAGTCAAAAGGCCTCTACGGTTTCATAACCCACAGATCCATTTCTTGGTCTACGCCTGGGACTCCACCTACAGAAAGTTTTCCACCA AAGTCACGCTGAATACAGTGGGGCACCACCACCGCCCCCCGCCCCATCAGGCCTCCGTTTCTGGAATCCAAGCAGAATTGCTCACATTTC CCAACTCCTCTCCTGGCCTCAGAAGACAGAAGAGAGACTGGGTTATTCCTCCCATCAGCTGCCCAGAAAATGAAAAAGGCCCATTTCCTA AAAACCTGGTTCAGATCAAATCCAACAAAGACAAAGAAGGCAAGGTTTTCTACAGCATCACTGGCCAAGGAGCTGACACACCCCCTGTTG GTGTCTTTATTATTGAAAGAGAAACAGGATGGCTGAAGGTGACAGAGCCTCTGGATAGAGAACGCATTGCCACATACACTCTCTTCTCTC ACGCTGTGTCATCCAACGGGAATGCAGTTGAGGATCCAATGGAGATTTTGATCACGGTAACCGATCAGAATGACAACAAGCCCGAATTCA CCCAGGAGGTCTTTAAGGGGTCTGTCATGGAAGGTGCTCTTCCAGGAACCTCTGTGATGGAGGTCACAGCCACAGACGCGGACGATGATG TGAACACCTACAATGCCGCCATCGCTTACACCATCCTCAGCCAAGATCCTGAGCTCCCTGACAAAAATATGTTCACCATTAACAGGAACA CAGGAGTCATCAGTGTGGTCACCACTGGGCTGGACCGAGAGAGTTTCCCTACGTATACCCTGGTGGTTCAAGCTGCTGACCTTCAAGGTG AGGGGTTAAGCACAACAGCAACAGCTGTGATCACAGTCACTGACACCAACGATAATCCTCCGATCTTCAATCCCACCACGGGCTTGGATT TTGAGGCCAAGCAGCAGTACATTCTACACGTAGCAGTGACGAATGTGGTACCTTTTGAGGTCTCTCTCACCACCTCCACAGCCACCGTCA CCGTGGATGTGCTGGATGTGAATGAAGCCCCCATCTTTGTGCCTCCTGAAAAGAGAGTGGAAGTGTCCGAGGACTTTGGCGTGGGCCAGG AAATCACATCCTACACTGCCCAGGAGCCAGACACATTTATGGAACAGAAAATAACATATCGGATTTGGAGAGACACTGCCAACTGGCTGG AGATTAATCCGGACACTGGTGCCATTTCCACTCGGGCTGAGCTGGACAGGGAGGATTTTGAGCACGTGAAGAACAGCACGTACACAGCCC TAATCATAGCTACAGACAATGGTTCTCCAGTTGCTACTGGAACAGGGACACTTCTGCTGATCCTGTCTGATGTGAATGACAACGCCCCCA TACCAGAACCTCGAACTATATTCTTCTGTGAGAGGAATCCAAAGCCTCAGGTCATAAACATCATTGATGCAGACCTTCCTCCCAATACAT CTCCCTTCACAGCAGAACTAACACACGGGGCGAGTGCCAACTGGACCATTCAGTACAACGACCCAACCCAAGAATCTATCATTTTGAAGC CAAAGATGGCCTTAGAGGTGGGTGACTACAAAATCAATCTCAAGCTCATGGATAACCAGAATAAAGACCAAGTGACCACCTTAGAGGTCA GCGTGTGTGACTGTGAAGGGGCCGCTGGCGTCTGTAGGAAGGCACAGCCTGTCGAAGCAGGATTGCAAATTCCTGCCATTCTGGGGATTC TTGGAGGAATTCTTGCTTTGCTAATTCTGATTCTGCTGCTCTTGCTGTTTCTTCGGAGGAGAGCGGTGGTCAAAGAGCCCTTACTGCCCC CAGAGGATGACACCCGGGACAACGTTTATTACTATGATGAAGAAGGAGGCGGAGAAGAGGACCAGGACTTTGACTTGAGCCAGCTGCACA GGGGCCTGGACGCTCGGCCTGAAGTGACTCGTAACGACGTTGCACCAACCCTCATGAGTGTCCCCCGGTATCTTCCCCGCCCTGCCAATC CCGATGAAATTGGAAATTTTATTGATGAAAATCTGAAAGCGGCTGATACTGACCCCACAGCCCCGCCTTATGATTCTCTGCTCGTGTTTG ACTATGAAGGAAGCGGTTCCGAAGCTGCTAGTCTGAGCTCCCTGAACTCCTCAGAGTCAGACAAAGACCAGGACTATGACTACTTGAACG AATGGGGCAATCGCTTCAAGAAGCTGGCTGACATGTACGGAGGCGGCGAGGACGACTAGGGGACTCGAGAGAGGCGGGCCCCAGACCCAT >In-frame_ENST00000506945_ENST00000422392_TCGA-A2-A4RW-01A_NADK2_chr5_36207272_-_CDH1_chr16_68835573_length(amino acids)=795AA_start in transcript=821_stop in transcript=3208 MRFQLMMVHGKNRRVQGSICVLEQDQRPVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLRFHNPQIHFLVYAWDSTYRKFSTKVTL NTVGHHHRPPPHQASVSGIQAELLTFPNSSPGLRRQKRDWVIPPISCPENEKGPFPKNLVQIKSNKDKEGKVFYSITGQGADTPPVGVFI IERETGWLKVTEPLDRERIATYTLFSHAVSSNGNAVEDPMEILITVTDQNDNKPEFTQEVFKGSVMEGALPGTSVMEVTATDADDDVNTY NAAIAYTILSQDPELPDKNMFTINRNTGVISVVTTGLDRESFPTYTLVVQAADLQGEGLSTTATAVITVTDTNDNPPIFNPTTGLDFEAK QQYILHVAVTNVVPFEVSLTTSTATVTVDVLDVNEAPIFVPPEKRVEVSEDFGVGQEITSYTAQEPDTFMEQKITYRIWRDTANWLEINP DTGAISTRAELDREDFEHVKNSTYTALIIATDNGSPVATGTGTLLLILSDVNDNAPIPEPRTIFFCERNPKPQVINIIDADLPPNTSPFT AELTHGASANWTIQYNDPTQESIILKPKMALEVGDYKINLKLMDNQNKDQVTTLEVSVCDCEGAAGVCRKAQPVEAGLQIPAILGILGGI LALLILILLLLLFLRRRAVVKEPLLPPEDDTRDNVYYYDEEGGGEEDQDFDLSQLHRGLDARPEVTRNDVAPTLMSVPRYLPRPANPDEI -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for NADK2-CDH1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for NADK2-CDH1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for NADK2-CDH1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | NADK2 | C1857252 | 2,4-Dienoyl-CoA Reductase Deficiency | 5 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET |
| Tgene | CDH1 | C1708349 | Hereditary Diffuse Gastric Cancer | 15 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | CDH1 | C0346153 | Breast Cancer, Familial | 12 | CLINGEN |
| Tgene | CDH1 | C0009405 | Hereditary Nonpolyposis Colorectal Neoplasms | 6 | CLINGEN |
| Tgene | CDH1 | C0024623 | Malignant neoplasm of stomach | 6 | CGI;CTD_human;UNIPROT |
| Tgene | CDH1 | C0038356 | Stomach Neoplasms | 6 | CGI;CTD_human |
| Tgene | CDH1 | C1112155 | Hereditary non-polyposis colorectal cancer syndrome | 6 | CLINGEN |
| Tgene | CDH1 | C1333990 | Hereditary Nonpolyposis Colorectal Cancer | 6 | CLINGEN |
| Tgene | CDH1 | C1333991 | Hereditary Non-Polyposis Colon Cancer Type 2 | 6 | CLINGEN |
| Tgene | CDH1 | C2936783 | Colorectal cancer, hereditary nonpolyposis, type 1 | 6 | CLINGEN |
| Tgene | CDH1 | C0006142 | Malignant neoplasm of breast | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Tgene | CDH1 | C0033578 | Prostatic Neoplasms | 4 | CTD_human |
| Tgene | CDH1 | C0376358 | Malignant neoplasm of prostate | 4 | CTD_human;GENOMICS_ENGLAND |
| Tgene | CDH1 | C0678222 | Breast Carcinoma | 4 | CTD_human |
| Tgene | CDH1 | C1257931 | Mammary Neoplasms, Human | 4 | CTD_human |
| Tgene | CDH1 | C1458155 | Mammary Neoplasms | 4 | CTD_human |
| Tgene | CDH1 | C4704874 | Mammary Carcinoma, Human | 4 | CTD_human |
| Tgene | CDH1 | C0007097 | Carcinoma | 3 | CTD_human |
| Tgene | CDH1 | C0205696 | Anaplastic carcinoma | 3 | CTD_human |
| Tgene | CDH1 | C0205697 | Carcinoma, Spindle-Cell | 3 | CTD_human |
| Tgene | CDH1 | C0205698 | Undifferentiated carcinoma | 3 | CTD_human |
| Tgene | CDH1 | C0205699 | Carcinomatosis | 3 | CTD_human |
| Tgene | CDH1 | C0005684 | Malignant neoplasm of urinary bladder | 2 | CTD_human |
| Tgene | CDH1 | C0005695 | Bladder Neoplasm | 2 | CTD_human |
| Tgene | CDH1 | C0009402 | Colorectal Carcinoma | 2 | CTD_human |
| Tgene | CDH1 | C0009404 | Colorectal Neoplasms | 2 | CTD_human |
| Tgene | CDH1 | C0019207 | Hepatoma, Morris | 2 | CTD_human |
| Tgene | CDH1 | C0019208 | Hepatoma, Novikoff | 2 | CTD_human |
| Tgene | CDH1 | C0021367 | Mammary Ductal Carcinoma | 2 | CTD_human |
| Tgene | CDH1 | C0023904 | Liver Neoplasms, Experimental | 2 | CTD_human |
| Tgene | CDH1 | C0027626 | Neoplasm Invasiveness | 2 | CTD_human |
| Tgene | CDH1 | C0027627 | Neoplasm Metastasis | 2 | CTD_human |
| Tgene | CDH1 | C0086404 | Experimental Hepatoma | 2 | CTD_human |
| Tgene | CDH1 | C0206692 | Carcinoma, Lobular | 2 | CGI;CTD_human;UNIPROT |
| Tgene | CDH1 | C1134719 | Invasive Ductal Breast Carcinoma | 2 | CTD_human |
| Tgene | CDH1 | C2931456 | Prostate cancer, familial | 2 | CTD_human |
| Tgene | CDH1 | C4551988 | BLEPHAROCHEILODONTIC SYNDROME 1 | 2 | GENOMICS_ENGLAND;UNIPROT |
| Tgene | CDH1 | C4722327 | PROSTATE CANCER, HEREDITARY, 1 | 2 | CTD_human |
| Tgene | CDH1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
| Tgene | CDH1 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
| Tgene | CDH1 | C0009324 | Ulcerative Colitis | 1 | CTD_human |
| Tgene | CDH1 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Tgene | CDH1 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
| Tgene | CDH1 | C0014476 | Eperythrozoonosis | 1 | CTD_human |
| Tgene | CDH1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| Tgene | CDH1 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Tgene | CDH1 | C0025500 | Mesothelioma | 1 | CTD_human |
| Tgene | CDH1 | C0026936 | Mycoplasma Infections | 1 | CTD_human |
| Tgene | CDH1 | C0027645 | Neoplasm Seeding | 1 | CTD_human |
| Tgene | CDH1 | C0027659 | Neoplasms, Experimental | 1 | CTD_human |
| Tgene | CDH1 | C0027746 | Nerve Degeneration | 1 | CTD_human |
| Tgene | CDH1 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
| Tgene | CDH1 | C0032927 | Precancerous Conditions | 1 | CTD_human |
| Tgene | CDH1 | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
| Tgene | CDH1 | C0079487 | Helicobacter Infections | 1 | CTD_human |
| Tgene | CDH1 | C0158646 | Cleft palate with cleft lip | 1 | ORPHANET |
| Tgene | CDH1 | C0220636 | Malignant neoplasm of salivary gland | 1 | CTD_human |
| Tgene | CDH1 | C0235874 | Disease Exacerbation | 1 | CTD_human |
| Tgene | CDH1 | C0282313 | Condition, Preneoplastic | 1 | CTD_human |
| Tgene | CDH1 | C0282612 | Prostatic Intraepithelial Neoplasias | 1 | CTD_human |
| Tgene | CDH1 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
| Tgene | CDH1 | C0476089 | Endometrial Carcinoma | 1 | CTD_human;GENOMICS_ENGLAND |
| Tgene | CDH1 | C0919267 | ovarian neoplasm | 1 | CTD_human |
| Tgene | CDH1 | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Tgene | CDH1 | C1176475 | Ductal Carcinoma | 1 | CTD_human |
| Tgene | CDH1 | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |
| Tgene | CDH1 | C1861536 | Blepharo-cheilo-dontic syndrome | 1 | ORPHANET |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies